Bayer has created a five-point plan in response to recent adverse court decisions on the alleged carcinogenicity of glyphosate.

The company will: -

• Create and promote a new website with scientific studies relevant to the safety of RoundUp™
• The company will consider whether it is prudent to package and distribute products for residential lawn and gardens given that most of the claims have emanated from this market segment.
• Bayer will establish an independent science advisory panel to review future claims.
• The company will continue to negotiate settlements based on presentation of scientific data.
• The two adverse verdicts representing bellwether plaintiffs will continue through the legal system with appeals in progress. Results may influence future action by the company.